Skip to main content

Editas Medicine, Inc 10-Q for FY2022 Q2

Editas Medicine, Inc. (EDIT)

10-Q 2022-08-03 For: 2022-06-30
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on August 3, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).

Headline figures

Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$6.36M
up 1578.6% from $379K a year earlier
Net loss
$53.45M
compared with a net loss of $55.26M a year earlier
Diluted EPS
-$0.78
compared with -$0.81 a year earlier